Skip to main content
logo
ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
30.15
+0.10 (0.33%)
At close: Sep 1, 2026, 4:00 PM EDT
30.46
+0.31 (1.03%)
Pre-market: Sep 2, 2026, 9:06 AM EDT

ArriVent BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,487831898---
Market Cap Growth
91.66%-7.48%----
Enterprise Value
1,114530615---
Last Close Price
30.1520.1226.64---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.972.703.48---
P/TBV Ratio
4.052.703.48---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.0000.000.000.00-
Net Debt / Equity Ratio
-1.02-1.02-0.85-0.99-0.94-0.90
Quick Ratio
13.4012.0612.7013.0019.6020.64
Current Ratio
14.1612.8313.1413.7621.8523.63
Return on Equity (ROE)
-53.25%-58.88%-39.36%-42.57%-34.22%-
Return on Assets (ROA)
-33.11%-36.49%-26.91%-26.95%-20.42%-
Return on Capital Employed (ROCE)
-48.00%-57.80%-36.60%-49.20%-21.20%-28.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.05%-20.02%-8.97%---
Buyback Yield / Dilution
-30.39%-22.22%-1369.88%-67.64%-79.57%-
SEC Filings: 10-K · 10-Q